BioSpace News Archive

Mission Therapeutics and AbbVie announced their DUB inhibitor collaboration back in 2018.

Vicarious Surgical to Present at the Canaccord Genuity 41 st Annual Growth Conference

GoodRx , Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, and Boehringer Ingelheim , a privately owned, leading global biopharmaceutical company, today announced a new joint effort to increase access to patient savings programs on the GoodRx platform.

YishengBio Co., Ltd (“YishengBio”) today announced that it received IND clearance for PIKA recombinant COVID-19 vaccine (CHO cell, S Protein) to conduct Phase I clinical trial from New Zealand Medicines and Medical Devices Safety Authority (“MEDSAFE”), which was following a similar IND approval by the United Arab Emirates Ministry of Health & Prevention.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that nearly 6,000 people with amyotrophic lateral sclerosis (ALS) in the U.S. have received treatment with RADICAVA® (edaravone) since it became available to patients four years ago.

Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka), a subsidiary of Otsuka Pharmaceutical Co., Ltd., announces that it has been awarded a grant for up to $17.8 million from the Bill & Melinda Gates Foundation.

Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global Consumer Staples Virtual Conference on Friday, September 10th. Thibaut Mongon, Executive Vice President Worldwide Chairman, Consumer Health will represent the Company in a session scheduled at 9:20 a.m. (Eastern Time).

Amber Specialty Pharmacy announces that it will begin dispensing REZUROCK™ (belumosudil) tablets for chronic graft-versus-host disease (cGVHD) to patients throughout the United States. REZUROCK is manufactured by Kadmon, headquartered in New York City, New York, and is the first and only FDA-approved small molecule inhibitor of ROCK2, a signaling pathway that modulates inflammatory responses and fibrotic processes.

To date, the Company has been servicing TV and film production companies in Toronto and Vancouver. Adding our new Montreal location positions the Company for additional growth and revenue.

Dr. Stene brings a record of accomplishment in guiding biotech companies through the process of achieving clinical laboratory accreditation.